Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 free fatty acid-based composition intended for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. Matinas BioPharma Holdings, Inc. has a research collaboration with the National Institute of Allergy and Infectious Diseases for the development of Gilead's antiviral remdesivir; and a feasibility collaboration with Genentech, Inc. for the development of oral formulations. The company was incorporated in 2013 and is based in Bedminster, New Jersey. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Matinas Biopharma Holdings Inc..
Matinas Biopharma Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Matinas Biopharma Holdings Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Matinas Biopharma Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Matinas Biopharma Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Matinas Biopharma Holdings Inc. and all latest updates of the company are provided.
The 2025 version of Matinas Biopharma Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Matinas Biopharma Holdings Inc.- Key Facts
2.2 Matinas Biopharma Holdings Inc.- Geographic Locations
2.3 Matinas Biopharma Holdings Inc.- Subsidiaries and Affiliates
2.4 Matinas Biopharma Holdings Inc.- Business Divisions
2.5 Matinas Biopharma Holdings Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Matinas Biopharma Holdings Inc. Strategic Analysis Review
3.1 Matinas Biopharma Holdings Inc.- Key Strategies
3.2 Matinas Biopharma Holdings Inc.- Company Outlook Statement
3.3 Matinas Biopharma Holdings Inc.- SWOT Analysis
3.3.1 Matinas Biopharma Holdings Inc.- Key Strengths
3.3.2 Matinas Biopharma Holdings Inc.- Key Weaknesses
3.3.3 Matinas Biopharma Holdings Inc.- Potential Opportunities
3.3.4 Matinas Biopharma Holdings Inc.- Potential Threats
3.4 Matinas Biopharma Holdings Inc.- Key Competitors
4. Business Description of the Company
4.1 Matinas Biopharma Holdings Inc.- Business Overview
4.2 Matinas Biopharma Holdings Inc.- Operations by Segment
5 Products and Services Details
5.1 Matinas Biopharma Holdings Inc.- Key Products
5.2 Matinas Biopharma Holdings Inc.- Key Service Areas
5.3 Matinas Biopharma Holdings Inc.- Key Brands
6 Company Developments
6.1 Matinas Biopharma Holdings Inc.- Company History
6.2 Matinas Biopharma Holdings Inc.- Latest Developments
7 Financial Analysis
7.1 Matinas Biopharma Holdings Inc.- Income Statements
7.2 Matinas Biopharma Holdings Inc.- Balance Sheet
7.3 Matinas Biopharma Holdings Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Matinas Biopharma Holdings Inc.- Direct Competitors
8.2 Matinas Biopharma Holdings Inc.- Competitor Financial Ratios comparison
8.3 Matinas Biopharma Holdings Inc.- Competitor Stock Charts Comparison
8.4 Matinas Biopharma Holdings Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!